RxDoctor Payments Data

Eric Stakebake

Physician Assistant · Lakeland, FLNPI 1619215738

Payments from drug & device makers

$8,044in general payments, 2019–2025

Across 322 payments — averaging $24.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Johnson & Johnson$745
  • Regeneron Healthcare Solutions, Inc.$657
  • UCB, Inc.$564
  • Pfizer$487
  • Novartis$345
  • plus $3K from 24 others

What the payments were for

  • Speaking & faculty fees$7509%
  • Food & beverage$6,99287%
  • Education$3034%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,044 in reported general payments places this provider in the 95th percentile of 8,062 physician assistant providers in Florida.

See all physician assistant providers in Florida

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab99$371,549
Skyrizi PenRisankizumab-Rzaa17$354,817
SkyriziRisankizumab-Rzaa16$337,305
Cosentyx Unoready PenSecukinumab18$181,740
Dupixent SyringeDupilumab39$153,323
Humira(Cf) PenAdalimumab14$133,745
OpzeluraRuxolitinib Phosphate39$79,347
JubliaEfinaconazole26$20,051
Ciclopirox574$16,133
Ammonium Lactate454$13,504
Ketoconazole394$7,677
Tacrolimus33$4,916
Hydrocortisone260$4,370
Metronidazole46$3,371
Mometasone Furoate111$2,998

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieSkyrizi$2,297$337,30516 claims
Incyte CorporationOpzelura$39$79,34739 claims
Ortho Dermatologics, A Division Of Bausch Health US, LLCJublia$104$20,05126 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,062 physician assistant providers in Florida.

Other physician assistant in Lakeland

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →